Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost Effectiveness of Glargine Insulin Versus NPH Insulin in Diabetic Patients in Iran

NCT01832935 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.

NCT NCT01832935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01832935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cost Effectiveness of Glargine Insulin Versus NPH Insulin in Diabetic Patients in Iran
Lead sponsor
Tehran University of Medical Sciences
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2011
Completion date
July 31, 2012
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus